Your browser doesn't support javascript.
loading
Long-term health impacts of COVID-19 among 242,712 adults in England.
Atchison, Christina J; Davies, Bethan; Cooper, Emily; Lound, Adam; Whitaker, Matthew; Hampshire, Adam; Azor, Adriana; Donnelly, Christl A; Chadeau-Hyam, Marc; Cooke, Graham S; Ward, Helen; Elliott, Paul.
Afiliação
  • Atchison CJ; School of Public Health, Imperial College London, London, UK.
  • Davies B; Imperial College Healthcare NHS Trust, London, UK.
  • Cooper E; School of Public Health, Imperial College London, London, UK.
  • Lound A; Imperial College Healthcare NHS Trust, London, UK.
  • Whitaker M; MRC Centre for Environment and Health, Imperial College London, London, UK.
  • Hampshire A; School of Public Health, Imperial College London, London, UK.
  • Azor A; School of Public Health, Imperial College London, London, UK.
  • Donnelly CA; School of Public Health, Imperial College London, London, UK.
  • Chadeau-Hyam M; MRC Centre for Environment and Health, Imperial College London, London, UK.
  • Cooke GS; Department of Brain Sciences, Imperial College London, London, UK.
  • Ward H; Department of Brain Sciences, Imperial College London, London, UK.
  • Elliott P; School of Public Health, Imperial College London, London, UK.
Nat Commun ; 14(1): 6588, 2023 10 24.
Article em En | MEDLINE | ID: mdl-37875536
The COVID-19 pandemic is having a lasting impact on health and well-being. We compare current self-reported health, quality of life and symptom profiles for people with ongoing symptoms following COVID-19 to those who have never tested positive for SARS-CoV-2 infection and those who have recovered from COVID-19. Overall, 276,840/800,000 (34·6%) of invited participants took part. Mental health and health-related quality of life were worse among participants with ongoing persistent symptoms post-COVID compared with those who had never had COVID-19 or had recovered. In this study, median duration of COVID-related symptoms (N = 130,251) was 1·3 weeks (inter-quartile range 6 days to 2 weeks), with 7·5% and 5·2% reporting ongoing symptoms ≥12 weeks and ≥52 weeks respectively. Female sex, ≥1 comorbidity and being infected when Wild-type variant was dominant were associated with higher probability of symptoms lasting ≥12 weeks and longer recovery time in those with persistent symptoms. Although COVID-19 is usually of short duration, some adults experience persistent and burdensome illness.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Limite: Adult / Female / Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Limite: Adult / Female / Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2023 Tipo de documento: Article